XPONANCE LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001637541
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 1816 positions · Total reported value $17.24B · Top-10 concentration 40.0% · Updated 2026-11-13
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
Turnover: 57.6% · 40 new · 979 cut · 65 exited
Active Share (vs S&P 500): 12.7% · vs QQQ: 44.9% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2026 13F filing, XPONANCE LLC disclosed 1816 equity positions with a combined reported value of $17.24B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.0% of reported value. HoldingsHub classifies the profile as Large / Technology Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were NVDA ($1.58B), AAPL ($1.22B), MSFT ($944.04M). By sector, the heaviest allocations are Technology 50.6%, Consumer Discretionary 13.0%. Versus the prior quarter, allocation shifted toward Technology (+2.1pp) and away from Consumer Discretionary (-0.6pp), Industrials (-1.1pp).
Versus the prior quarter, XPONANCE LLC opened 40 new positions, trimmed 979 and fully exited 65, a turnover rate of 57.6% of positions. The portfolio's overlap with the prior quarter was 94% of names.
The largest new positions opened in Q3 2026 were SKHY ($1.48M), IWM ($629.42K), BHP ($390.52K).
Of the 65 positions fully exited versus the prior quarter, the largest were EA ($10.37M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- SKHY SK HYNIX INC · $1.48M
- IWM ISHARES TR · $629.42K
- BHP BHP BILLITON LIMITED · $390.52K
- MBGL MOBILITY GLOBAL INC · $373.58K
- KOD KODIAK SCIENCES INC · $351.71K
- ATRC ATRICURE INC · $324.72K
- CDNA CAREDX INC · $315.57K
- ALC ALCON AG · $311.90K
Fully Exited (vs previous quarter)
- EA Elanco Animal Health Inc · prev qtr: $10.37M
Insider Transactions (Form 4)
Latest XPONANCE LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
XPONANCE LLC is a quantitative investment management firm based in Philadelphia, PA, that manages US equity positions using systematic strategies.
Investment Approach
Employs systematic, data-driven strategies using proprietary quantitative models.
Asset Classes
Primarily focused on US equities with sophisticated risk management.
Scale
Manages approximately $23.9 billion in assets under management according to SEC Form ADV.
Official disclosures available through SEC filings.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
6.93M | $1.58B | 9.19% | Add | |
| 2 |
|
3.66M | $1.22B | 7.08% | Add | |
| 3 |
|
1.84M | $944.04M | 5.48% | Add | |
| 4 |
|
1.73M | $596.33M | 3.46% | Add | |
| 5 |
|
2.05M | $509.58M | 2.96% | Add | |
| 6 |
|
1.37M | $480.06M | 2.79% | Add | |
| 7 |
|
1.40M | $478.46M | 2.78% | Add | |
| 8 |
|
608.19K | $441.05M | 2.56% | Add | |
| 9 |
|
330.58K | $352.11M | 2.04% | Add | |
| 10 |
|
841.21K | $298.47M | 1.73% | Add | |
| 11 |
|
480.66K | $294.05M | 1.71% | Add | |
| 12 |
|
229.67K | $265.74M | 1.54% | Add | |
| 13 |
|
493.82K | $177.44M | 1.03% | Add | |
| 14 |
|
524.79K | $173.62M | 1.01% | Add | |
| 15 |
|
319.12K | $158.91M | 0.92% | Add | |
| 16 |
|
234.22K | $129.17M | 0.75% | Add | |
| 17 |
|
474.39K | $125.59M | 0.73% | Add | |
| 18 |
|
377.27K | $123.94M | 0.72% | Add | |
| 19 |
|
235.37K | $120.37M | 0.70% | Add | |
| 20 |
|
626.14K | $117.12M | 0.68% | Add | |
| 21 |
|
702.36K | $114.31M | 0.66% | Add | |
| 22 |
|
924.25K | $111.12M | 0.65% | Add | |
| 23 |
|
125.92K | $102.09M | 0.59% | Add | |
| 24 |
|
110.81K | $100.87M | 0.58% | Add | |
| 25 |
|
240.69K | $95.63M | 0.56% | Add | |
| 26 |
|
363.83K | $95.17M | 0.55% | Add | |
| 27 |
|
295.25K | $92.20M | 0.54% | Add | |
| 28 |
|
856.74K | $89.03M | 0.52% | Add | |
| 29 |
|
807.88K | $86.95M | 0.50% | Add | |
| 30 |
|
1.24M | $86.15M | 0.50% | Add | |
| 31 |
|
300.97K | $79.68M | 0.46% | Add | |
| 32 |
|
389.38K | $75.90M | 0.44% | Add | |
| 33 |
|
1.39M | $75.58M | 0.44% | Add | |
| 34 |
|
873.75K | $75.21M | 0.44% | Add | |
| 35 |
|
267.40K | $74.90M | 0.43% | Add | |
| 36 |
|
261.71K | $74.45M | 0.43% | Add | |
| 37 |
|
42.59K | $74.09M | 0.43% | Add | |
| 38 |
|
359.12K | $73.34M | 0.42% | Add | |
| 39 |
|
76.42K | $72.63M | 0.42% | Add | |
| 40 |
|
488.36K | $70.96M | 0.41% | Add | |
| 41 |
|
503.25K | $69.10M | 0.40% | Add | |
| 42 |
|
259.10K | $68.46M | 0.40% | Add | |
| 43 |
|
180.16K | $66.13M | 0.38% | Add | |
| 44 |
|
313.99K | $63.93M | 0.37% | Add | |
| 45 |
|
438.43K | $63.70M | 0.37% | Add | |
| 46 |
|
708.74K | $59.75M | 0.35% | Add | |
| 47 |
|
138.97K | $58.58M | 0.34% | Add | |
| 48 |
|
56.19K | $50.59M | 0.29% | Add | |
| 49 |
|
261.51K | $49.90M | 0.29% | Add | |
| 50 |
|
73.89K | $49.88M | 0.29% | Add | |
FAQ
What did XPONANCE LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, XPONANCE LLC reported 1816 equity positions worth $17.24B in aggregate; its largest disclosed positions were NVDA ($1.58B), AAPL ($1.22B), MSFT ($944.04M).
How large is XPONANCE LLC's portfolio?
XPONANCE LLC reported $17.24B of long equity holdings across 1816 positions as of 2026-Q3. Top-10 holdings account for 40.0% of reported value.
What is XPONANCE LLC's investment style?
HoldingsHub classifies the portfolio as Large / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.